IBO Insider Trading Activity and SEC Form 4 Filings
IBO insider trading summary
Over the past 12 months, insiders at Impact Biomedical Inc. (IBO) reported 5 sales worth $27K by 2 insiders and no open-market purchases on SEC Form 4. Net insider selling was $27K.
Latest IBO insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Sep 24, 2026 | Dss, Inc. | 10% Owner | Sell | $1K (156 @ $7.06) |
| Sep 23, 2026 | Dss, Inc. | 10% Owner | Sell | $188 (27 @ $6.95) |
| Sep 22, 2026 | Dss, Inc. | 10% Owner | Sell | $398 (723 @ $0.55) |
| Mar 27, 2026 | Todd D Macko | Chief Financial Officer | Sell | $24K (43,400 @ $0.56) |
| Mar 25, 2026 | Todd D Macko | Chief Financial Officer | Sell | $961 (1,600 @ $0.60) |
| May 27, 2025 | Dss, Inc. | 10% Owner | Sell | $25K (45,400 @ $0.54) |
| May 27, 2025 | Dss, Inc. | 10% Owner | Sell | $25K (45,400 @ $0.54) |
| May 22, 2025 | Dss, Inc. | 10% Owner | Sell | $63K (115,600 @ $0.55) |
| May 22, 2025 | Dss, Inc. | 10% Owner | Sell | $63K (115,600 @ $0.55) |
| Apr 4, 2025 | Heng Fai Ambrose Chan | Director | Sell | $173K (180,000 @ $0.96) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.